This content is only available within our institutional offering.
27 Jul 2017
N+1 Singer - Morning Song 27-07-2017
Renishaw plc (RSW:LON), 3,428 | Bodycote plc (BOY:LON), 689 | Burford Capital Limited (BUR:LON), 688 | Itaconix plc (ITX:LON), 119 | Brooks Macdonald Group plc (BRK:LON), 1,608 | abrdn Diversified Income and Growth PLC GBP (ADIG:LON), 28.1 | Oxford BioMedica plc (OXB:LON), 632
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
N+1 Singer - Morning Song 27-07-2017
Renishaw plc (RSW:LON), 3,428 | Bodycote plc (BOY:LON), 689 | Burford Capital Limited (BUR:LON), 688 | Itaconix plc (ITX:LON), 119 | Brooks Macdonald Group plc (BRK:LON), 1,608 | abrdn Diversified Income and Growth PLC GBP (ADIG:LON), 28.1 | Oxford BioMedica plc (OXB:LON), 632
- Published:
27 Jul 2017 -
Author:
Singer CM Team -
Pages:
17 -
Aberdeen Diversified Income & Growth Trust (ADIG LN) Unconstrained and flexible approach | accesso Technology (ACSO LN) Six Flags miss not a red flag | Bodycote (BOY LN) Good growth for H1 17, guidance raised to upper end of expectations | Brewin Dolphin Holdings (BRW LN) Positive Q3 update, upgraded 394p target price | Brooks Macdonald Group (BRK LN) Strong Q4 net inflows but additional cost investment planned | Burford Capital (BUR LN) Exceptionally strong first half results | Itaconix (ITX LN) First application agreement under AkzoNobel collaboration | Oxford BioMedica (OXB LN) Forecasts updated for new Novartis supply agreement | Renishaw (RSW LN) Strong growth for FY17, confident of further progress for FY18